Lung Cancer News and Research

Latest Lung Cancer News and Research

New therapeutic strategy for lung cancer and associated secondary tumors

In 20 - 40% of patients with cancer, metastasis (the development of secondary tumors) in the central nervous system (CNS) occurs. CNS metastatis impacts negatively on a patient's quality of life, and is associated with a poor health prognosis.

8 Feb 2020

Largest genome study sheds light on how genetic glitches trigger tumor formation

It is well-known that when a gene mutates, it triggers tumor formation by stimulating abnormal cell growth and proliferation. Cancer starts from a mutant gene that kickstarts a series of abnormal growth, forming a tumor. However, the exact mechanism of how this happens remains unclear.

6 Feb 2020

Purdue-developed 'fluorescent markers' begin Phase 3 clinical trials

On Target Laboratories Inc., a privately held biotechnology company developing the use of Purdue University-discovered fluorescent markers to target and illuminate cancer during surgery, has announced the results of a multi-institutional Phase 2 clinical trial in which outcomes were improved for 26% of patients undergoing pulmonary resection for non-small-cell lung cancer.

6 Feb 2020

Researchers compile large catalog of cancer mutations

Mutations in 38 different types of cancer have been mapped by means of whole genome analysis by an international team of researchers from, amongst others, the University of Copenhagen, Aarhus University, Aarhus University Hospital, and Rigshospitalet.

6 Feb 2020

SEER: A better tool to image disease

Scientists from the University of South California (USC) report the development of a novel technique to image living cells in greater detail and increased clarity. The study, published in the journal Nature Communications, describes a technology which can confer the ability to actually see things going wrong – a great advantage in the study of health and disease.

5 Feb 2020

Cancer deaths down by 29 percent over last two decades

The American Cancer Society reports that cancer deaths in the United States have decreased by as much as 29 percent between 1991 and 2017, thanks to early detection and treatment advances.

5 Feb 2020

Study uncovers higher lung cancer rates in young women across multiple countries

An International Journal of Cancer study that examined lung cancer rates in young adults in 40 countries across five continents uncovered a trend of higher lung cancer rates in women compared with men in recent years.

5 Feb 2020

Analysis shows overall survival in lung cancer patients harboring 'niche' mutations

Mutations were observed in all genes studied, except c-MET, DDR2, MAP2K1, and RET.

5 Feb 2020

Practo Insights: Appointments with oncologists increase by 94% in India

Cancer cases in India have doubled in recent years. According to reports, India’s cancer incidence was estimated at 1.15 million new patients in 2018 and is predicted to almost double by 2040.

4 Feb 2020

Cross Party Group acknowledges need for early lung cancer screening in Scotland

The need to consider a formal recommendation on early screening for lung cancer was acknowledged by the Cross Party Group for Cancer, held at the Scottish Parliament in Edinburgh on January 21st 2020.

3 Feb 2020

Quitting smoking reverses lung cell damage even for decade-long smokers

It’s never too late to quit smoking, as a new study shows the lung’s ability to heal and regrow damaged cells caused by cigarette smoking, even if they smoked for decades.

30 Jan 2020

Ex-smokers’ lungs can almost “magically” replenish themselves

Researchers have identified a type of lung cell that can almost “magically” replenish the lining of airways in people who have given up smoking.

30 Jan 2020

Annual lung cancer screening with LDCT reduces lung cancer deaths

The Dutch-Belgian Randomized Lung Cancer Screening Trial, known as the NELSON trial (de Koning et. al), published Jan. 29 in the New England Journal of Medicine (NEJM), reconfirms that annual lung cancer screening with low-dose computed tomography (LDCT) in high-risk patients significantly reduces lung cancer deaths.

30 Jan 2020

Interleukin-1-beta-induced chronic inflammation promotes lung cancer metastasis

The study reveals a detailed epigenetic mechanism for how interleukin-1-beta, a common cytokine that helps fight infections during inflammation, plays a critical role in cancer metastasis.

29 Jan 2020

Study shows protective cells reduce lung cancer risk in ex-smokers

A new study could explain how lung cancer risk is reduced by quitting smoking. Published in the journal Nature in January 2020, the study shows that ex-smokers have a greater number of lung cells that have healthy genes compared to current smokers. Healthy genes are less likely to transform into cancerous cells.

29 Jan 2020

When aid-in-dying is legal, but the medicine is out of reach

The call came the last week of September, when Neil Mahoney could still stagger from his bed to the porch of his mobile home to let out his boisterous yellow Lab, Ryder.

29 Jan 2020

Prostate cancer is the most commonly diagnosed cancer in England

In the health agency’s report, there were 49,029 diagnoses made in 2018, which is about 8,000 more than the previous year, surpassing breast cancer with 47,476 cases. Lung cancer followed with 38,996 cases. The new data reveals that there were more cancers detected in 2018 in men than in women, with a total of 15,228 cases and 151,452, respectively.

28 Jan 2020

New technology enhances visualization of lung cancer tissue, helps improve patient outcomes

A groundbreaking tumor-highlighting technology- OTL38- enhances the visualization of lung cancer tissue, providing surgeons with a significantly better chance of finding and removing more cancer than previously possible, according to a scientific presentation at the 56th Annual Meeting of The Society of Thoracic Surgeons.

27 Jan 2020

Developing diagnostic tools based on science of the sniff

As the medical industry continues its quest for accurate and reliable diagnostic tools, more is becoming understood about the science of the sniff.

24 Jan 2020

RB1 alterations in cancer cells may lead to treatment resistance

The Cancer Genetics Group of the Josep Carreras Leukaemia Research Institute, led by Montse Sánchez-Céspedes, together with Luis Montuenga from CIMA, and Enriqueta Felip from Vall d'Hebron Hospital, has revealed that inactivation of RB1 through intragenic rearrangements is frequent in lung cancer cells from non-smoking patients with EGFR mutations.

24 Jan 2020